Garcia-Beltran Lab Awarded NIH High-Risk, High-Reward Award to Engineer NK-Cell Therapies for Solid Tumors
Oct 14, 2025 Features
The Garcia-Beltran Lab at the Ragon Institute, led by Wilfredo Garcia-Beltran, MD, PhD, has received a National Institutes of Health (NIH) High-Risk, High-Reward Research (HRHR) Program award to propel a new project that retools natural killer (NK) cells to better locate, enter, and destroy solid tumors. The HRHR program, part of the NIH Common Fund, […]